Cargando…

Neurodegeneration in Schizophrenia: Evidence from In Vivo Neuroimaging Studies

Although schizophrenia is primarily considered to be a neurodevelopmental disorder, there is a growing consensus that the disorder may also involve neurodegeneration. Recent research using non-invasive neuroimaging techniques, such as magnetic resonance imaging, suggests that some patients with schi...

Descripción completa

Detalles Bibliográficos
Autor principal: Csernansky, John G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901218/
https://www.ncbi.nlm.nih.gov/pubmed/17334606
http://dx.doi.org/10.1100/tsw.2007.47
_version_ 1783314567581925376
author Csernansky, John G.
author_facet Csernansky, John G.
author_sort Csernansky, John G.
collection PubMed
description Although schizophrenia is primarily considered to be a neurodevelopmental disorder, there is a growing consensus that the disorder may also involve neurodegeneration. Recent research using non-invasive neuroimaging techniques, such as magnetic resonance imaging, suggests that some patients with schizophrenia show progressive losses of gray matter in the frontal and temporal lobes of the brain. The cellular mechanisms responsible for such gray matter losses are unknown, but have been hypothesized to involve abnormal increases in apoptosis.
format Online
Article
Text
id pubmed-5901218
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher TheScientificWorldJOURNAL
record_format MEDLINE/PubMed
spelling pubmed-59012182018-06-03 Neurodegeneration in Schizophrenia: Evidence from In Vivo Neuroimaging Studies Csernansky, John G. ScientificWorldJournal Review Article Although schizophrenia is primarily considered to be a neurodevelopmental disorder, there is a growing consensus that the disorder may also involve neurodegeneration. Recent research using non-invasive neuroimaging techniques, such as magnetic resonance imaging, suggests that some patients with schizophrenia show progressive losses of gray matter in the frontal and temporal lobes of the brain. The cellular mechanisms responsible for such gray matter losses are unknown, but have been hypothesized to involve abnormal increases in apoptosis. TheScientificWorldJOURNAL 2007-02-02 /pmc/articles/PMC5901218/ /pubmed/17334606 http://dx.doi.org/10.1100/tsw.2007.47 Text en Copyright © 2007 John G. Csernansky. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Csernansky, John G.
Neurodegeneration in Schizophrenia: Evidence from In Vivo Neuroimaging Studies
title Neurodegeneration in Schizophrenia: Evidence from In Vivo Neuroimaging Studies
title_full Neurodegeneration in Schizophrenia: Evidence from In Vivo Neuroimaging Studies
title_fullStr Neurodegeneration in Schizophrenia: Evidence from In Vivo Neuroimaging Studies
title_full_unstemmed Neurodegeneration in Schizophrenia: Evidence from In Vivo Neuroimaging Studies
title_short Neurodegeneration in Schizophrenia: Evidence from In Vivo Neuroimaging Studies
title_sort neurodegeneration in schizophrenia: evidence from in vivo neuroimaging studies
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901218/
https://www.ncbi.nlm.nih.gov/pubmed/17334606
http://dx.doi.org/10.1100/tsw.2007.47
work_keys_str_mv AT csernanskyjohng neurodegenerationinschizophreniaevidencefrominvivoneuroimagingstudies